Search results for: 'dect intelligent pharma'
- Did you mean
- decis intelligent pharma
- d2cb intelligent pharma
- Related search terms
- pharmaceutical-industry-in-ghana-and-nigeria-18447
- pharmaceutical membrane filtration market analysis by product mce coated cellulose acetate nylon p1df membrane technique
- pharmaceutical R&D service market
- pharmaceutical industry market size of singapor
- dect health market
-
25 Jul 2024  |  Global  |  Technology Research
Intelligent Medical Triaging in Hospitals: Innovations and Growth Opportunities
Artificial Intelligence to Drive Growth and New Product Development
Medical triaging in hospitals has significant challenges, including long patient wait times, increased healthcare staff workload, risk of human error in triaging, and unsatisfactory patient outcomes, primarily due to manual triaging processes. These factors impact the quality and efficiency of patient triaging, creating an urgent need for innovativ...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Aug 2018  |  North America  |  Market Research
Artificial Intelligence Virtual Assistants in Healthcare—From Echo to the Enterprise
Improved Workflow, Operational Efficiency, and Customer Journey Will be Available to All Stakeholders
Frost & Sullivan research found the visible market success of artificial intelligence (AI)-driven interactive virtual assistants (IVAs), such as Alexa from Amazon and the Google Assistant, has been matched by specialized IVA deployments in various vertical markets such as financial services, education, and retail. Healthcare has presented opportun...
$1,500.00
Special Price $1,125.00 save 25 %
-
20 Jun 2025  |  Global  |  Technology Research
Recent Advances in Biologics, Microbiome Technologies, Intelligent Drug Discovery and Biomanufacturing Technologies
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent technology advances across cell & gene therapies, immunotherapies, intelligent drug discovery approaches, automated biomanufacturing and microbiome sciences. The TOE also encompasses recent developments in proteomics, drug deliver...
$950.00
Special Price $855.00 save 10 %
-
02 Jun 2020  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence for Healthcare IT, Global, 2020
Benchmarking Future Growth Potential
Frost & Sullivan research has identified the core areas in which artificial intelligence (AI)-enabled healtchcare IT solutions are most relevant for hospitals, physicians, and payers. Hospitals that have so far invested in AI-based financial solutions to automate patient access management, reimbursement eligibility matching, and computer-assisted ...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Aug 2026  |  Global  |  Market Research
Growth Opportunities in Real-Time Location Systems in the Healthcare Industry, Forecast to 2031
Operational Efficiency, Connected Healthcare Ecosystems, and AI-Enabled Intelligence Are Driving Transformational Growth in Healthcare RTLS
The global healthcare RTLS market is evolving beyond traditional asset tracking toward intelligent location platforms that enable real-time visibility, workflow optimization, and operational decision-making across healthcare environments. As healthcare providers continue investing in digital transformation, RTLS is increasingly being deployed as an...
$4,950.00 -
11 May 2026  |  Global  |  Market Research
Home Care Digitization Market, United States and Europe, 2026–2031
The Shift from Episodic to Intelligent, Data-driven Care is Driving Transformational Growth by Enabling Continuous, Risk-Driven Home Care
Home care digitalization continues to gain strong momentum, driven by the rapid growth of the elderly population, increasing prevalence of multi-morbidity, persistent workforce shortages, and rising cost and efficiency pressures on payers and public health systems. Population aging is not only increasing the volume of home care but also its complex...
$4,950.00 -
23 Aug 2019  |  Global  |  Market Outlook
Global Digital Health Outlook, 2020
Artificial Intelligence, Care Coordination, Cybersecurity, Data Analytics, Digital Therapeutics, and Telehealth Will Drive the Market
This study predicts the ways that artificial intelligence, care coordination cybersecurity, data analytics, digital therapeutics, and telehealth will drive the digital health market in 2020. The report presents 9 predictions that are likely to prevail by 2020. Frost & Sullivan defines digital health as the application of data to the delivery of hea...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Feb 2025  |  Global  |  Customer Research
Global Healthcare Cloud User Survey, Q3 2024
Artificial Intelligence Growth and the Shift to Cloud-native Applications and Edge Computing Drive the Digital Transformation
The story for 2024 is artificial intelligence (AI). Businesses across industries are scrambling to determine how they can leverage AI, particularly generative AI (GenAI), to meet their business goals. Public cloud providers are at the forefront of the effort to accelerate AI adoption among customers by developing foundational models and user-friend...
$4,950.00
Special Price $4,455.00 save 10 %
-
16 Dec 2025  |  Europe  |  Market Outlook
Top 10 Growth Opportunities in the European Life Sciences Industry, 2026
Transformational Policies Will Unlock Life Sciences Growth in 2026 Through AI-Enabled Innovation, Digital-Clinical Scale-Up, and Biomanufacturing Resilience
Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...
$2,450.00 -
24 Jun 2026  |  Global  |  Market Research
Top 5 Growth Opportunities in AI-Enabled Drug Discovery, 2026
Growing Precision Medicine Research is Driving Agile Partnerships with Newer OoC Technologies
As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...
$2,450.00